Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

CG Oncology, Inc. (CGON) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

CG Oncology, Inc. (CGON), most recent 12 months reported: revenue $6.23M, net loss $224.38M, free cash flow -$179.34M. Latest balance sheet on file: liquid cash $1.03B, total debt $3M, net cash $1.03B. From SEC filings. Others in Biological Products, (No Diagnostic Substances): Caribou Biosciences, Inc. · TSCAN THERAPEUTICS, INC. · ZEO SCIENTIFIX, INC · FATE THERAPEUTICS INC · Taysha Gene Therapies, Inc. · DBV Technologies S.A. · Prime Medicine, Inc. · OCUGEN, INC.

Stock screener

Watchlist